Helen YeonJu Chung: Reflections from My 1st World Federation of Hemophilia Congress
Helen YeonJu Chung, Senior Manager in Regional Marketing at Sysmex Asia Pacific, shared on LinkedIn:
”My first time attending the World Federation of Hemophilia Congress (WFH) – and it left a strong impression.
What stood out most wasn’t just the science, but the people.
Clinicians, lab professionals, patients, and advocates from all over the world, all in one place.
What I hadn’t seen before was patients attending scientific sessions – fully engaged, asking questions, and eager to learn.
That level of curiosity and ownership was powerful to witness.
You could feel a shared intent to turn knowledge into better haemophilia management and everyday quality of life.
It also reinforced something important for me: in diagnostics, we go beyond delivering results.
We are part of a broader ecosystem alongside pharma and healthcare providers, contributing to better monitoring, decisions, and peace of mind for patients.
Grateful to have been part of this experience with my knowledgeable Sysmex colleagues and KOLs – still a lot to learn, but moments like this remind me why it matters.”

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 10:00Benjamin Tur: Putting Iron Deficiency Anemia on the Global Agenda at the Paris Peace Forum’s Child Summit
-
Nov 14, 2026, 09:48Jack Shuang Hou: FDA Approves Bayer’s Sunharbo – First Factor XIa Inhibitor for Secondary Stroke Prevention
-
Nov 14, 2026, 09:42Samwel Mikaye: What Every Patient Should Know About DVT Symptoms and Treatment
-
Nov 14, 2026, 09:37Chronic Preoperative Corticosteroid Use and Postoperative Venous Thromboembolism Risk – Thrombosis and Haemostasis Journal
-
Nov 14, 2026, 09:30Ney Carter Borges: Vulnerable Plaque – Imaging and Clinical Significance
-
Nov 14, 2026, 09:25Carmelo Raffo: How Much Antithrombotic Therapy is Truly Necessary after LAAC?
-
Nov 14, 2026, 09:19Mary Cushman: Excellent to Have Jordan Shavit Visit Us for a Virtual Lab Meeting Today
-
Nov 14, 2026, 09:15Chancellor Donald: Heading to ASH 2026 in New Orleans? Let’s Connect on Faculty Opportunities at Tulane
-
Nov 14, 2026, 09:11Sajja Venkatesh: FDA Approved Asundexian, the First Factor XIa Inhibitor